Evaluation of molecular mechanisms of riboflavin anti-COVID-19 action reveals anti-inflammatory efficacy rather than antiviral activity

Roman A. Akasov, Olga E. Chepikova, Tatiana N. Pallaeva, Neonila V. Gorokhovets, Andrei E. Siniavin, Vladimir A. Gushchin, Lyudmila V. Savvateeva, Ivan A. Vinokurov, Dmitry A. Khochenkov, Andrey A. Zamyatnin, Evgeny V. Khaydukov

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Background: Riboflavin (vitamin B2) is one of the most important water-soluble vitamins and a coenzyme involved in many biochemical processes. It has previously been shown that adjuvant therapy with flavin mononucleotide (a water-soluble form of riboflavin) correlates with normalization of clinically relevant immune markers in patients with COVID-19, but the mechanism of this effect remains unclear. Here, the antiviral and anti-inflammatory effects of riboflavin were investigated to elucidate the molecular mechanisms underlying the riboflavin-induced effects. Methods: Riboflavin was evaluated for recombinant SARS-CoV-2 PLpro inhibition in an enzyme kinetic assay and for direct inhibition of SARS-CoV-2 replication in Vero E6 cells, as well as for anti-inflammatory activity in polysaccharide-induced inflammation models, including endothelial cells in vitro and acute lung inflammation in vivo. Results: For the first time, the ability of riboflavin at high concentrations (above 50 μM) to inhibit SARS-CoV-2 PLpro protease in vitro was demonstrated; however, no inhibition of viral replication in Vero E6 cells in vitro was found. At the same time, riboflavin exerted a pronounced anti-inflammatory effect in the polysaccharide-induced inflammation model, both in vitro, preventing polysaccharide-induced cell death, and in vivo, reducing inflammatory markers (IL-1β, IL-6, and TNF-α) and normalizing lung histology. Conclusions: It is concluded that riboflavin reveals anti-inflammatory rather than antiviral activity for SARS-CoV-2 infection. General significance: Riboflavin could be suggested as a promising compound for the therapy of inflammatory diseases of broad origin.

Original languageEnglish (US)
Article number130582
JournalBiochimica et Biophysica Acta - General Subjects
Volume1868
Issue number5
DOIs
StatePublished - May 2024
Externally publishedYes

Keywords

  • Cytokines
  • Inflammation
  • PLpro protease
  • Riboflavin
  • SARS-CoV-2

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology

Fingerprint

Dive into the research topics of 'Evaluation of molecular mechanisms of riboflavin anti-COVID-19 action reveals anti-inflammatory efficacy rather than antiviral activity'. Together they form a unique fingerprint.

Cite this